StockData
Alumis Inc. logo

Alumis Inc. (ALMS) stock

ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$4.33−0.06 (-1.48%)

Close on Nov 19, 2026Market cap $560.46MP/E –Yield –

Alumis free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Alumis's free cash flow for the twelve months ending Jun 30, 2026 was -$351.80M. For fiscal 2025 it was -$370.18M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$370.18M–
FY2024Dec 31, 2024-$256.81M–
FY2023Dec 31, 2023-$134.47M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$81.74M–
Q1 FY2026Mar 31, 2026-$87.25M–
Q4 FY2025Dec 31, 2025-$71.91M–
Q3 FY2025Sep 30, 2025-$110.91M–
Q2 FY2025Jun 30, 2025-$106.97M–
Q1 FY2025Mar 31, 2025-$80.39M–
Q4 FY2024Dec 31, 2024-$75.13M–
Q3 FY2024Sep 30, 2024-$84.55M–
Q2 FY2024Jun 30, 2024-$52.72M–
Q1 FY2024Mar 31, 2024-$44.42M–
Q4 FY2023Dec 31, 2023-$34.94M–
Q3 FY2023Sep 30, 2023-$35.42M–

More Alumis figures

See a number that looks wrong?